Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstracts - RGCON 2016
Case Report
Case Series
Commentary
Editorial
Erratum
Letter to Editor
Letter to the Editor
Media & News
Original Article
Point of Technique
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstracts - RGCON 2016
Case Report
Case Series
Commentary
Editorial
Erratum
Letter to Editor
Letter to the Editor
Media & News
Original Article
Point of Technique
Review Article
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstracts - RGCON 2016
Case Report
Case Series
Commentary
Editorial
Erratum
Letter to Editor
Letter to the Editor
Media & News
Original Article
Point of Technique
Review Article
View/Download PDF

Translate this page into:

Review Article
2026
:12;
13
doi:
10.25259/ASJO_72_2025

Head and neck cancer screening: Bridging gaps in early detection and equity

Department of Internal Medicine, University of Nevada, Reno School of Medicine, Nevada, USA,
Department of Medical Oncology, Paras Hospital, Gurugram, India.
Department of Internal Medicine, AI Falah School of Medical Sciences and Research, Dhauj, Faridabad, Haryana, India.

*Corresponding author: Mehak Budhiraja, Department of Internal Medicine, University of Nevada, Reno School of Medicine, Nevada, USA mehakbudhiraja7@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Budhiraja M, Gupta S, Budhiraja M. Head and neck cancer screening: Bridging gaps in early detection and equity. Asian J Oncol. 2026;12:13. doi: 10.25259/ASJO_72_2025

Abstract

Head and neck cancers (HNCs) represent a major global health challenge, ranking among the top ten cancers by incidence and mortality. India bears a disproportionate burden, accounting for 26.9% of the worldwide 890,000 cases in 2022, 239,817 new diagnoses per GLOBOCAN and ICMR-NCDIR estimates, with South Asia contributing one-third of global oral and pharyngeal cancers. High-risk behaviors drive this epidemic. Tobacco use affects 267 million Indians (bidis, khaini, gutkha prominent), alongside betel quid chewing, alcohol synergy, HPV (26% HNC prevalence), poor oral hygiene (>60% rural untreated dental issues), and malnutrition (13.7% undernourished).

Government efforts like the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) and Ayushman Bharat have screened 328 million people for oral cancer by 2023 using ASHA/ANM visual exams, mobile units (1,525 operational), and teleoncology platforms like OncoNet. Yet NFHS-5 data (2019-2021) show stark gaps: just 1.2% of men and 0.9% of women aged 30-49 screened, varying from 0% in Ladakh to 12-15% in southern states. Late presentations yield 30-50% five-year survival, versus 70% in developed nations.

This review synthesizes HNC epidemiology, regional/gender disparities, India-specific risks, screening landscapes, and barriers: workforce shortages, stigma, low awareness, financial strains, and digital divides. Targeted interventions like structured screening, HPV vaccination scale-up, could halve mortality as cases are predicted to double by 2050.

Keywords

Disparities
Epidemiology
Head and neck cancer
Incidence
India
Mortality
Oral cancer
Prevention
Risk factors
Socioeconomic factors
Tobacco

INTRODUCTION

Head and neck cancer epidemiology

According to the GLOBOCAN 2022, head and neck cancers (HNC) collectively rank among the top ten cancers worldwide in terms of incidence and mortality.[1] The proportion of HNC relative to all-site cancers is markedly higher in India compared to developed nations such as the USA, UK, and Australia, as well as developing regions.[2-4] In terms of regional burden, South Asia, especially India, carries a disproportionately high burden, accounting for approximately one-third of global cases of oral and pharyngeal cancers.[5] According to the ICMR-NCDIR 2020 estimates, India reported approximately 239,817 new cases of HNCs with an approximate number of 143,759 new lip and oral cavity cancer cases alone.[6] India constitutes a total of roughly 26.89% out of the global total of 0.89 million. Cancer cases in India are projected to nearly double by 2050, increasing from an estimated 2.4 million cases in 2022 to 4.8 million cases [Tables 1, 2 and Figure 1 ].

Table 1: Incidence of HNC
Year India (2012)[14] Global (2012)[15] India (2022)[1] Global (2022) India (2025-projected)[14] Global (2025- projected)[16]
Lip and oral cavity incidence 41,881 300,373 143,759 389,846 Tongue – 60608 Mouth - 90060 579,096
Pharyngeal cancer incidence (nasopharynx + oropharynx + hypopharynx) 23,023 Oropharynx-142,387; Nasopharynx-86,691 60,203 313,091 Hypopharynx – 23,124 450,420
Laryngeal cancer incidence 8497 larynx 156,877 35,855 188,191 Larynx – 34,506 293,944

HNC: Head and neck cancer

Table 2: Mortality
Year India (2012)[14] Global (2012) India (2022)[1] Global (2022) Global (2025- projected)[16]
Mortality from HNC (All types) 52,067 - oral cancer only[17] 97,919 (males) 47,409 (females) – lip and oral cavity[18] 375,000 (cumu- lative) 133,046 458,456 722,671

HNC: Head and neck cancer

India: Cancer cases by subtype
Figure 1: India: Cancer cases by subtype

Screening is vital for early detection, improving survival, reducing treatment costs, and enhancing quality of life.[7] Yet, population-based screening for HNCs remains inconsistent in India. These cancers impose a heavy burden due to disfigurement, speech and swallowing difficulties, limited awareness, and high recurrence.[8-11] Late-stage diagnosis contributes to poor five-year survival (30–50% vs. up to 70% in developed nations). Systematic population-based screening for head and neck cancers in India remains limited, with inconsistent integration into national cancer screening programs.[7,12-18]

Disparities in head and neck cancer burden in India

Regional

Population-Based Cancer Registries (PBCR) Report 2012-2014 presents the variation in HNC cases in different regions, along with their comparison to the international data from five continents. The key findings of the top 5 subsites among HNCs are represented in the graph [Figure 2].[19]

Highest reported AARs for head and neck cancer subtypes by gender
Figure 2: Highest reported AARs for head and neck cancer subtypes by gender

When ranking both national and international data, as per incidence the Top five positions for both genders were occupied by Indian PBCRs for all sub-sites except Nasopharynx and Larynx in males.

Data from Hospital-Based Cancer Registries (HBCR) Report 2012–2016 showed the mouth was the leading site in TMH (14%), Dibrugarh (14.9%), Guwahati (12.7%), and Chennai (9.7%) amongst males. In females, Cancer mouth was commoner in Bangalore (9.9%) and Guwahati (5.1%).[20]

Gender

HNCs show a marked male predominance. In India, men account for over 70% of HNC cases (1,90,928 of 2,47,924 cases).[1] Previous studies have reported a male-to-female ratio for HNC cases in the Indian population ranging from 2:1 to 5:1, although the gap is narrowing in urban regions due to changing lifestyle patterns.[21,22] According to GLOBOCAN 2022 data, the age-standardized incidence rate (ASIR) for lip and oral cavity cancers in India was 14.7 per 100,000 for men and 5.0 per 100,000 for women, highlighting a significant gender disparity. This is due to higher exposure to tobacco, alcohol, and occupational risks. In India, the lifetime risk of developing HNC is 1 in 33 for males and 1 in 107 for females.

According to the second round of Global Adult Tobacco Survey (GATS) data of 2016-17, 42.4% of males, and 14.2% of females use tobacco in India.[23] This disparity may be due to the social stigma surrounding tobacco use among women in the state, contributing to its lower prevalence in females. As per a study done in Biharstudy population was rural Indian tobacco chewers, 91% were male. In comparison, pan chewing was reported in 65% of males and 35% of females.[24]GATS 2009-2010 reported Dual tobacco use significantly higher in men (9.3%) than women (1.1%), with a male: female ratio of 8.5:1. Women showed greater susceptibility to SLT-related oral cancers, with a meta-analysis reporting an OR of 12.4 in women versus 4.7 in men [Figures 3 and 4].[25]

Global head and neck cancer incidence trends (2012, 2022, 2025)
Figure 3: Global head and neck cancer incidence trends (2012, 2022, 2025)
Head and neck cancer (HNC) mortality trends
Figure 4: Head and neck cancer (HNC) mortality trends

Current screening landscape

Government initiatives

Launched in 2010, the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) opportunistic screening for common cancers, including oral, breast, and cervical cancers, at the primary health care level. Trained Accredited Social Health Activists (ASHAs) and Auxiliary Nurse Midwives (ANMs) conduct visual oral cavity examinations during population-based screening of individuals aged 30 years and above.[26]

The AYUSH Bharat program, through its Integrative Health Clinics and Wellness Centers, facilitates early detection of cancers such as oral and head-neck malignancies via community-based outreach aligned with traditional health practices. The Ayushman Arogya Mandir initiative, under Ayushman Bharat, delivers comprehensive primary health care including screening for common cancers. As of December 15, 2023, these centers have conducted 32.8 crore oral cancer screenings.[27,28]

Pilot programs, mobile screening units, and tele-oncology

The National Mobile Medical Units (NMMUs), implemented under the National Health Mission (NHM), enhance healthcare accessibility in remote and underserved regions through mobile facilities such as medical vans, boat clinics, dental and eye units, functioning under both rural and urban health missions. As of June 2023, 1,525 units were operational nationwide, ensuring delivery of essential services in hard-to-reach areas. Mobile technology has also been leveraged for oral cancer screening; mobile applications like Oncogrid have demonstrated high accuracy in early detection, achieving a 90% confirmation rate for malignant or potentially malignant lesions during community-based screening.[28,29]

OncoNet-Kerala, developed by the Centre for Development of Advanced Computing (C-DAC), pioneered teleoncology in India by linking the Regional Cancer Centre, Thiruvananthapuram, with peripheral hospitals to support early diagnosis, follow-up, treatment, prevention, and tele-education. Complementary initiatives such as ‘Swasth Kiosks’ offer free cancer screening and awareness services across multiple sites. Building on these models, the Ministry of Health and Family Welfare launched OncoNet India, an integrated tele-oncology network, connecting Regional and Peripheral Cancer Centers nationwide. Similarly, mobile medical units like that conducted by the Sri Venkateswara Institute of Cancer Care and Advanced Research (SVICCAR), Tirupati, expand outreach for oral cancer screening in underserved populations.[30,31]

Public–private partnerships have further strengthened cancer control efforts. Tata Trusts, in collaboration with the Tata Memorial Centre, operate diagnostic mobile units in rural and semi-urban areas for detection of oral precancerous lesions and have established major oncology institutions such as the Tata Memorial Hospital and Tata Medical Center. Joint ventures like the Assam Cancer Care Foundation, initiated by Tata Trusts and the Government of Assam, aim to build India’s first statewide cancer care grid to improve accessibility, affordability, and continuity of cancer treatment.[31]

Among Non-profit initiatives, Biocon Limited’s mHealth-based Oral Cancer Screening Program facilitates early detection through remote image-based evaluation by specialists, screening over 70,000 individuals and training more than 1,000 frontline workers since 2011. The Alamelu Charitable Foundation advances equitable cancer care by establishing and equipping treatment centers to enhance accessibility for underserved populations.[31,32]

The NFHS-5 (2019–2021) survey revealed persistently low oral cancer screening coverage across India, with only 1.2% of men and 0.9% of women aged 30–49 undergoing screening.[33] Participation rates varied widely by region, ranging from 0% in Ladakh and Lakshadweep to 6.3% in Andhra Pradesh and 10.1% among women in the Andaman and Nicobar Islands. Southern states such as Tamil Nadu and Kerala demonstrated relatively higher coverage (12– 15%) supported by stronger public health systems, whereas several northern states, including Uttar Pradesh and Bihar, reported rates below 5% due to infrastructural and workforce limitations. Strikingly, even high-incidence regions such as East Khasi Hills in Meghalaya (78.5 per 100,000) showed minimal screening participation (1.2%).[29-34]

Barriers to screening for head and neck cancer

Workforce shortages and urban-rural disparities

India faces uneven distribution of screening centers, diagnostic facilities, and trained ENT specialists or dentists. As of 2020, there were fewer than eight doctors per 10,000 population and around 12,000 ENT specialists, mostly concentrated in urban areas.[35,36] Cancer screening and pathology services are similarly , with fewer than 500 oncopathologists nationwide. NFHS-5 highlighted the need for better infrastructure, trained personnel, and consistent reporting systems for oral cancer screening.[34]

Cultural barriers and stigma

Social stigma surrounding tobacco and alcohol use, both of which are major causes of HNCs, disclosure and screening. Misconceptions such as cancer being contagious, a curse, or untreatable remain widespread.[37,38] Many rely on traditional healers before seeking formal care. Studies show limited awareness about smokeless tobacco (SLT) risks, with many perceiving it as harmless or even beneficial.[39] Youth-targeted marketing of tobacco products and weak enforcement of the Cigarettes and Other Tobacco Products Act 2003 (COTPA) trade/distribution, contributed to early SLT use. Despite regulations, compliance remains poor, especially around educational institutions, perpetuating the problem.[40,41]

Lack of awareness and health literacy

Limited awareness of HNC symptoms and screening remains a key barrier, especially in rural areas. Public education largely focuses on breast and cervical cancer, leaving HNCs overlooked. Studies reveal that while many have heard of oral cancer, few recognize its symptoms or risk factors.[42,43]Delayed help-seeking, often due to misinterpreting warning signs, leads to late-stage presentations with over 80% diagnosed at advanced stages in some tertiary centers.[44,45]

Financial constraints and lack of insurance coverage

High medical costs and inadequate insurance hinder participation in screening programs. Despite free government screening, follow-up investigations and treatment often require out-of-pocket spending.[46] Over 80% of Indians lack health insurance, with 70% of total health expenditure being private and mostly paid directly by households. Many resort to borrowing or selling assets for treatment, pushing millions into poverty each year.[45,46]

Technological barriers

Digital health initiatives using mobile apps, SMS reminders, and AI tools show promise in enhancing cancer awareness and screening accessibility.[47] However, poor internet connectivity, limited device compatibility, and digital illiteracy, especially in rural and elderly populations, restrict their reach. Digital health adoption for noncommunicable diseases in India remains limited compared to developed countries.[48]

Risk factors for head and neck cancers

HNCs are closely associated with identifiable and modifiable risk factors. Risk profiles differ globally, influenced by socioeconomic, cultural, and environmental factors. These factors often interact synergistically, compounding the risk.

India is a developing country with a lower-middle-income economy and a medium Human Development Index (HDI).[49,50]Understanding these risk determinants is critical for shaping public health interventions, especially in countries where the burden of HNC is disproportionately high. A unique risk environment prevails due to the widespread use of smokeless tobacco, betel quid chewing, early initiation of risk behaviors, limited early detection infrastructure, poor public awareness, and sociocultural practices.

Tobacco use

Tobacco is the leading risk factor for head and neck cancers worldwide, contributing to 50–60% of cases, with smokers facing a nearly 10-fold increased risk of head and neck squamous cell carcinoma compared to never-smokers.[51]In India, over 267 million users consume diverse forms, including bidis (smoked by 71.8 million adults, or 14% of smokers) and smokeless tobacco (SLT) such as khaini - a tobacco, lime mixture - the most commonly used tobacco product, being used by every ninth adult (17.9% of men), gutkha - a tobacco, lime, areca nut mixture (6.8%), and betel quid with tobacco (5.8%), deeply embedded in rural cultural practices.[23,52,53] Bidi smoking delivers higher nicotine and tar than cigarettes, elevating risks for oral, pharyngeal, and laryngeal cancers, while Indian SLT products contain potent carcinogens like tobacco-specific nitrosamines (TSNAs), areca nut-derived nitrosamines, toxic metals, and PAHs.[54-56]SLT use is strongly linked to precancerous lesions, with nearly 70% of oral cancers preceded by conditions like leukoplakia and oral submucous fibrosis (OSF), particularly rising among youth.[56]

Alcohol consumption

Alcohol is an independent carcinogen and acts synergistically with tobacco.[57] Alcohol is implicated in approximately 70% of HNC cases globally, and when combined with tobacco, the risk may increase up to 40-fold.[58] Data from the 2017 NMB survey reported a higher prevalence of alcohol (8.7%) than tobacco use (7.9%) in India, with significantly greater use among males (15.8%) than females (2.4%).[59] In another population study, over 50% of Indian alcohol users were also tobacco users, indicating substantial co-abuse.[60] The INHANCE Consortium’s large-scale pooled study found that among never-smokers, consuming ≥3 alcoholic drinks per day significantly increased the risk of HNC (OR 2.04; 95% CI: 1.29–3.21), particularly for oropharyngeal and hypopharyngeal cancers.[61]

Human papillomavirus (HPV)

Recent evidence links rising HNSCC rates to HPV infection, despite declining tobacco use.[62] In 2012, about 38,000 HNC cases were linked to HPV globally, with a disproportionately higher burden in developed countries compared to less developed ones. Approximately 30% of oropharyngeal cancers that mainly affect the tonsils and base of the tongue are HPV-related, accounting for around 29,000 cases annually. In contrast, HPV was associated with fewer cases of the oral cavity (4,400) and laryngeal cancers (3,800), based on limited case series data. The World Cancer Report 2012 attributed 30.8% of oropharyngeal cancers to HPV, compared to just 2.2% for oral cavities and 2.4% for laryngeal cancers.[63] Particularly in developed countries, the burden of oropharyngeal cancers associated with high-risk HPV types has increased significantly.[64,65] The average prevalence rate of HPV DNA-positive HNC in India is 26%, based on a review of PCR-based studies, mainly focused on OSCC.[66]

HPV vaccination, particularly quadrivalent and nonavalent vaccines targeting HPV-16/18, holds promise for reducing oropharyngeal cancer incidence, yet national coverage remains low at approximately 1.3% among girls aged 15-18 years per NFHS-5 data, with inclusion into the Universal Immunization Program for ages 9-14 years pending despite endorsement by the National Technical Advisory Group on Immunization (NTAGI).[67,68] Pilot vaccination programs in Punjab and Sikkim achieved coverage rates exceeding 90%, demonstrating feasibility and acceptance for broader rollout to curb India’s estimated 121,302 HPV-related cancers by 2025.[69]

Other viral infections

The Epstein–Barr virus (EBV) has been firmly established as a major etiological agent in the pathogenesis of NPC since 1973.[70] Although studies done on the Indian population with EBV-related nasopharyngeal carcinoma are rare, significant evidence suggests a positive correlation between the two.[71] Furthermore, several studies have reported associations between hepatitis B and C infections and HNC. HCV prevalence was 7.8% in HNC cases, 12.8% in HNSCC and 3.4% in other HNC types, while HBV was present in about 11% of nasopharyngeal carcinoma patients.[72-76]

Poor oral hygiene (POH) and dental health

POH is strongly associated with an elevated risk of oral cancer and may enhance the carcinogenic effects of known risk factors such as tobacco and alcohol. This association persists even after adjusting for confounders including tobacco use, alcohol consumption, education level, and socioeconomic status.[77] POH is common, particularly in low-income groups. According to the National Oral Health Survey, over 60% of rural Indians have untreated dental problems, increasing their cancer risk. Tooth brushing ≥2 times/day, dental visits, denture use, and ≥3 caries were linked to reduced risk of oral, pharyngeal, and laryngeal cancers. Conversely, >5 missing teeth, gum bleeding, periodontal disease, and mouthwash use were associated with increased oral cancer risk.[78] According to a study by WHO, dental caries prevalence in India ranged from 23.0% to 71.5% in 12-year-olds, 48.1% to 86.4% in adults (35–45 years), and 51.6% to 95.1% in the elderly (65–74 years). Periodontal disease prevalence ranged from 15.3% to 77.9% in adults and 19.9% to 96.1% in the elderly.[79]

Poor diet and nutrition

Diets low in fruits and vegetables, often due to socioeconomic deprivation, may increase HNC risk by approximately 2-fold. Between 2021 and 2023, an estimated 194.6 million people in India were undernourished, according to the FAO. Additionally, the 2024 SOFI report by the United Nations highlights that 55.6% of India’s population cannot afford a healthy diet, underscoring the country’s significant nutritional and food security challenges.

Occupational and environmental exposures

India, the largest pesticide producer in Asia and the twelfth globally in usage, faces widespread exposure risks due to its predominantly agrarian population.[80] Many are engaged in outdoor work, such as farming or manual labor, leading to prolonged sun exposure which is a recognized risk factor for lip cancer.[81]

Poor education and socioeconomic status

Illiteracy, poverty, and lack of awareness contribute to higher exposure to risk factors and delayed healthcare-seeking.[7]As per a study done in Bihar 26% (47 out of 179) of tobacco chewers were illiterate, whereas only 7.2% (13 out of 179) held a graduate degree. The majority (59%) reported a monthly income ranging between Rs. 5,000 and Rs. 10,000. In terms of occupation, 32% were farmers and 22% were laborers.[24]

CONCLUSION

India faces an escalating HNC challenge with 239,817 cases in 2020, amid projections of 4.8 million total cancers by 2050, fueled by tobacco (50-60% attributable), betel quid, alcohol, HPV, poor oral hygiene, and socioeconomic vulnerabilities in a medium-HDI context. Despite advances like NPCDCS visual screening, Ayushman Bharat's 328 million exams, Oncogrid AI, 1,525 mobile units, and teleoncology networks, NFHS-5 reveals <1% average uptake, with northern states lagging at <5% versus 12-15% in the south.

Persistent barriers compound late-stage diagnoses (80%): ENT/pathologist shortages (12,000/500 specialists), cultural stigma delaying disclosure, symptom misinterpretation (87.5%), out-of-pocket costs pushing 63 million into poverty yearly (80% uninsured), and technological gaps in rural areas. Promising pilots, like Punjab/Sikkim HPV vaccination (>90% coverage), highlight feasibility despite national delays.

Urgent priorities include expanding population-based visual/tactile screening with AI integration, strengthening COTPA enforcement and SLT bans, incorporating HPV vaccination into the Universal Immunization Program for ages 9-14, upskilling workforces through public-private partnerships like Tata Trusts, launching misconception-targeted awareness campaigns, and subsidizing diagnostics with structured referrals. These coordinated strategies, focused on high-burden regions, promise early detection, risk reduction, and economic relief, mirroring cervical cancer successes to achieve equitable HNC control.

Author contributions:

MeB, SG, MiB: Conception, literature review, manuscript drafting, critical revision, and approval of the final manuscript.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient's consent not required as there are no patients in this study.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. GLOBOCAN 2022: Estimated cancer incidence, mortality and prevalence worldwide in 2022. Global Cancer Observatory 2022 [accessed 2025 May 31]
    [Google Scholar]
  2. , , , , , , et al. Cancer Incidence in Five Continents, Vol. XI [Electronic version] 2017 [accessed 2025 May 31]. https://ci5.iarc.fr
    [Google Scholar]
  3. . Cancer Incidence and Mortality Data Colombo District, Sri Lanka (Population-Based Cancer Registry): 2013-2019. 2021 [accessed 2025 May 31]. https://www.nccp.health.gov.lk/storage/post/pdfs/PCBR%20Books.pdf
    [Google Scholar]
  4. , , , , , , et al. Cancer incidence and mortality in selected districts of Nepal in 2019. . Kathmandu: Nepal Health Research Council; [accessed 2025 May 31]. https://nhrc.gov.np/wpcontent/uploads/2022/08/Population-Based-Cancer-Registry-Report-2019-1.pdf
    [Google Scholar]
  5. , , , , , , . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.
    [CrossRef] [PubMed] [Google Scholar]
  6. . National Centre for Disease Informatics and Research. National Cancer Registry Programme Report 2020: Consolidated Report of Population-Based Cancer Registries 2012-2016. 2020 [accessed 2025 May 31]. https://ncdirindia.org/All_Reports/PBCR_REPORT_2012_2016/index.htm
    [Google Scholar]
  7. , , , , , , et al. Screening for head and neck cancers: A systematic review. JAMA Otolaryngol Head Neck Surg. 2023;149:1047-56.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Quality of life for head and neck cancer patients: A bibliographic analysis. Cancers (Basel). 2023;15:4551.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , , , , , et al. Factors influencing quality of life in head and neck cancer survivors. Semin Oncol Nurs. 2022;38:151256.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , , , , et al. Functional outcomes in head and neck cancer patients. Cancers (Basel). 2022;14:2135.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , , , et al. Head and neck cancer. Lancet. 2008;371:1695-1709.
    [CrossRef] [PubMed] [Google Scholar]
  12. . Resource-stratified guidelines. . Mumbai, India: Tata Memorial Centre; [accessed 2025 May 31]. https://www.ncgindia.org/assets/ncg-guidelines-2021/ncg-guidelines-manual-2021.pdf
    [Google Scholar]
  13. , , , , , , et al. Opportunistic screening of oral potentially malignant disorders in India. JCO Glob Oncol. 2020;6:1226-34.
    [CrossRef] [PubMed] [Google Scholar]
  14. . Three-Year Report of Population-Based Cancer Registries 2012-2014. . Bengaluru, India: Indian Council of Medical Research; [accessed 2025 May 31]. https://www.icmr.gov.in/icmrobject/static/icmr/dist/images/pdf/reports/Preliminary_Pages_Printed1.pdf
    [Google Scholar]
  15. , , , , , . Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108.
    [CrossRef] [PubMed] [Google Scholar]
  16. . Cancer Tomorrow. . Lyon, France: World Health Organization; [accessed 2025 May 31]. https://cancertomorrow.iarc.fr/
    [Google Scholar]
  17. . Cancer India. Ministry of Health and Family Welfare, Government of India. [accessed 2025 May 31]. https://cancerindia.org.in/
    [Google Scholar]
  18. , , . Global epidemiology of head and neck cancers: A continuing challenge. Oncology. 2016;91:13-23.
    [CrossRef] [PubMed] [Google Scholar]
  19. . Indian Council of Medical Research. Three-Year Report of Population Based Cancer Registries 2012-2014. . Bengaluru, India: National Centre for Disease Informatics and Research; [accessed 2025 May 31]. https://ncdirindia.org/All_Reports/PBCR_REPORT_2012_2014/ALL_CONTENT/PDF_Printed_Version/Preliminary_Pages_Printed.pdf
    [Google Scholar]
  20. . Indian Council of Medical Research. Hospital-Based Cancer Registries Report 2012-2016. . Bengaluru: NCRP; [accessed May 31 2025] https://www.ncdirindia.org/Reports.aspx
    [Google Scholar]
  21. , , , . Site specific effect of tobacco addiction in upper aerodigestive tract tumors: A retrospective clinicopathological study. Sci World J. 2014;2014:460194.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , , , et al. Changing trends in oral cancer-A global scenario. Nepal J Epidemiol. 2016;6:613-9.
    [CrossRef] [PubMed] [Google Scholar]
  23. . Global Adult Tobacco Survey: India 2016-17. [accessed 2025 May 31]. https://ntcp.mohfw.gov.in/assets/document/surveys-reports
    [Google Scholar]
  24. , , , , , , et al. Oral smokeless tobacco consumption pattern among rural Indian cancer patients: A prospective survey. South Asian J Cancer. 2020;9:17-9.
    [CrossRef] [PubMed] [Google Scholar]
  25. . Global Adult Tobacco Survey: India 2009-2010. [accessed 2025 May 31]. https://ntcp.mohfw.gov.in/assets/document/surveys-reports-publications/Global-Adult-Tobacco-Survey-India-2009-2010-Report.pdf
    [Google Scholar]
  26. . Training Manual on Oral Care for ASHA. . National Health Systems Resource Centre. [accessed 2025 May 31]. https://nhsrcindia.org
    [Google Scholar]
  27. . Health and Family Welfare Statistics in India 2023. . New Delhi: MoHFW; [accessed 2025 May 31]. https://mohfw.gov.in
    [Google Scholar]
  28. . Ministry of Health and Family Welfare initiatives and achievements 2023. Published December 27 2023. [accessed 2025 May 31]. https://pib.gov.in
    [Google Scholar]
  29. , , , , , , et al. Mobile health application for remote oral cancer surveillance. J Am Dent Assoc. 2015;146:886-94.
    [CrossRef] [PubMed] [Google Scholar]
  30. . Detailed Project Report: ONCONET India - Cancer Care for Rural Masses In: Doc. No: DPR CI 122 0001 Issue No: 1. Thiruvananthapuram, India: C-DAC. . [accessed 2025 May 31]
    [Google Scholar]
  31. . Tata Trusts: Transforming cancer care delivery in India. Indian J Surg Oncol. 2022;13(Suppl1):91-5.
    [CrossRef] [PubMed] [Google Scholar]
  32. . Biocon Foundation wins IHW Gold Award for disease screening initiative of the year 2022. Published January 24 2023 [accessed 2025 May 31]. https://www.biocon.com
    [Google Scholar]
  33. , , . Status of cancer screening in India: NFHS-5. J Fam Med Prim Care. 2022;11:7303.
    [CrossRef] [PubMed] [Google Scholar]
  34. . National Family Health Survey-5 (2019-20) Published 2021 [accessed 2025 May 31]. http://rchiips.org
    [Google Scholar]
  35. . National Health Workforce Accounts database. Geneva: WHO; [accessed 2025 May 31]. https://apps.who.int
    [Google Scholar]
  36. . Improving health workforce data and evidence. Geneva: WHO; [accessed 2025 May 31]. https://www.who.int
    [Google Scholar]
  37. . Debunk the myths: Oncologic misconceptions. Indian J Med Res. 2014;139:185-87.
    [Google Scholar]
  38. , . Oral cancer myths and challenges in Indian population. Indian Cancer Awareness J. 2023;2:3-6.
    [CrossRef] [Google Scholar]
  39. , , , . First contact for curative health care in rural India. Indian J Med Res. 2011;134:627-38.
    [CrossRef] [PubMed] [Google Scholar]
  40. . Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce. . Production, Supply and Distribution) Act, 2003 New Delhi, India: Ministry of Law and Justice. [accessed 2025 May 31]. http://www.indiacode.nic.in/handle/123456789/2053
    [Google Scholar]
  41. , , , . COTPA implementation status in South India. Indian J Med Res. 2022;156:508-15.
    [CrossRef] [PubMed] [Google Scholar]
  42. , , , , , , et al. Awareness regarding cancer risk factors in India. Asian Pac J Cancer Prev. 2012;13:4057-62.
    [CrossRef] [PubMed] [Google Scholar]
  43. , , , , , , et al. Knowledge and screening for oral, breast, and cervical cancer in Northeast India. JCO Glob Oncol. 2020;6:601-09.
    [CrossRef] [PubMed] [Google Scholar]
  44. , , , . Factors causing delay in diagnosis of head and neck malignancy. Int J Otorhinolaryngol Head Neck Surg. 2018;4(03):708-711. [accessed 2025 May 31]
    [CrossRef] [Google Scholar]
  45. , , , , , , et al. Diagnostic delay for head and neck cancer in South India. Asian Pac J Cancer Prev. 2020;21:1673-78.
    [CrossRef] [PubMed] [Google Scholar]
  46. . Current situation of health care coverage in India. ISPOR News Across Asia. 2016;5:1-6.
    [Google Scholar]
  47. , , . Social support and digital literacy among older adults. J Appl Gerontol. 2017;36:29-55.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , , , , , et al. Digital interventions for non-communicable diseases in India. Digit Health. 2019;5:2055207619896153.
    [CrossRef] [PubMed] [Google Scholar]
  49. . Human Development Reports. New York, NY: United Nations Development Programme; [accessed 2025 May 31]. https://hdr.undp.org/
    [Google Scholar]
  50. . World Bank Country and Lending Groups: Country Classification by Income Level. Washington, DC: The World Bank Group; [accessed 2025 May 31]. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519
    [Google Scholar]
  51. . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume. 83 Tobacco Smoke and Involuntary Smoking 2004:53-1187. [accessed 2025 May 31]. https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono83.pdf
    [Google Scholar]
  52. , , , . The Tobacco Atlas (3rd ed). Atlanta, GA: American Cancer Society; .
    [Google Scholar]
  53. , , , , , , et al. Association of smokeless tobacco use and oral cancer: A systematic review and meta-analysis. Nicotine Tob Res. 2019;21:1162-71.
    [CrossRef] [PubMed] [Google Scholar]
  54. , , , , , , et al. Patterns and related factors of bidi smoking in India. Indian J Cancer. 2020;57:S58-65.
    [CrossRef] [PubMed] [Google Scholar]
  55. , , , . Association of tobacco habits with site-specific cancer incidence: Mumbai cohort study. Cancer Causes Control. 2011;22:859-68.
    [CrossRef] [PubMed] [Google Scholar]
  56. , , , , , eds. Smokeless Tobacco and Public Health in India. . New Delhi: Ministry of Health & Family Welfare, Government of India. [accessed 2025 May 31]. https://ntcp.mohfw.gov.in/assets/document/surveys-reports-publications/Smokeless-Tobacco-and-Public-Health-in-India.pdf
    [Google Scholar]
  57. . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. . Vol. 44 Alcohol Drinking. Lyon, France: IARC; [accessed 2025 May 31]. https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Monographs-OnThe-Identification-Of-Carcinogenic-Hazards-To-Humans/Alcohol-Drinking-1988
    [Google Scholar]
  58. , , , , . Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci. 2023;11:42.
    [CrossRef] [PubMed] [Google Scholar]
  59. , , , , , , et al. Prevalence of alcohol and tobacco use in India and implications for COVID-19. J Med Life. 2020;13:499-509.
    [CrossRef] [PubMed] [Google Scholar]
  60. , , , . Concurrent alcohol and tobacco use in Mumbai. Natl Med J India. 2005;18:88-91.
    [Google Scholar]
  61. , , , , , , et al. Interaction between tobacco and alcohol use and head and neck cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18:541-50.
    [CrossRef] [PubMed] [Google Scholar]
  62. . Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2007;Vol 90:90-636.
    [Google Scholar]
  63. , , , . Worldwide burden of cancer attributable to HPV. Int J Cancer. 2017;141:664-70.
    [CrossRef] [PubMed] [Google Scholar]
  64. , , , , , , et al. Development and validation of a staging system for HPV-related oropharyngeal cancer. Lancet Oncol. 2016;17:440-51.
    [CrossRef] [PubMed] [Google Scholar]
  65. , , , . Dynamics of oral HPV infection in healthy population and head and neck cancer. Cancer Med. 2023;12:5190-5202.
    [CrossRef] [PubMed] [Google Scholar]
  66. , , , , , , et al. HPV-attributable head and neck cancers in India: A systematic review and meta-analysis. JCO Glob Oncol. 2024;10:e2400164.
    [CrossRef] [PubMed] [Google Scholar]
  67. National Family Health Survey (NFHS-5), India 2019-2021.
    [Google Scholar]
  68. , , , , , , et al. Current status of HPV vaccination in India. Indian J Med Res. 2023;157:141-46.
    [Google Scholar]
  69. , , , , , , et al. Pilot HPV vaccination program in Punjab. Vaccine. 2024;42:658-66.
    [Google Scholar]
  70. , , . EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature. 1973;244:245-47.
    [CrossRef] [PubMed] [Google Scholar]
  71. , , , , , , et al. Effects of hepatitis B virus infection on nasopharyngeal carcinoma prognosis. Cancer Med. 2020;9:541-51.
    [CrossRef] [PubMed] [Google Scholar]
  72. , , , , , , et al. Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients. J Cancer Res Ther. 2020;16:619-26.
    [CrossRef] [PubMed] [Google Scholar]
  73. , , , , , , et al. HCV infection and risk of head and neck cancer: A meta-analysis. Oral Oncol2020;. ;109:104869.
    [CrossRef] [PubMed] [Google Scholar]
  74. , , , , , , et al. Epidemiological correlations between head and neck cancer and hepatitis B core antibody positivity. Anticancer Res. 2020;40:2393-403.
    [CrossRef] [PubMed] [Google Scholar]
  75. , , . Hepatitis C virus infection and prognosis of head and neck cancer. Oral Oncol. 2018;87:138-43.
    [CrossRef] [PubMed] [Google Scholar]
  76. , , , , . Role of poor oral hygiene in oral cancer. Indian J Surg Oncol. 2019;10:184-95.
    [CrossRef] [PubMed] [Google Scholar]
  77. , , , , , , et al. Association between oral hygiene and head and neck cancer: A meta-analysis. Acta Odontol Scand. 2023;81:374-95.
    [CrossRef] [PubMed] [Google Scholar]
  78. , , , , , , et al. Oral Health in India: A multicentric study New Delhi: Directorate General of Health Services; .
    [Google Scholar]
  79. , . Pesticide use and application: An Indian scenario. J Hazard Mater. 2009;165:1-12.
    [CrossRef] [PubMed] [Google Scholar]
  80. . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 55 Solar and Ultraviolet Radiation 1992 [accessed 2025 May 31]. https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Solar-And-Ultraviolet-Radiation-1992
    [Google Scholar]
  81. . National Family Health Survey-5 (2019-20) Published 2021 [accessed 2025 May 31]. http://rchiips.org
    [Google Scholar]
Show Sections